Article PDF
References
Staszewiki S, Morales-Ramires J, Tashima K, et al. Efavirenz plus ziduvudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infections in adults. N Engl J Med 1999;16:1865–73.
Kupperman BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and the prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;155:575–82.
Whitcup SM, Butler KM, Caruso R, de Smet MD, Rubin B, Husson RN, et al. Retinal toxicity in human immunodeficiency virus-infected children treated with 2′,3′ -dideoxyinosine. Am J Ophthalmol 1992;113:1–7.
Cobo J, Ruiz MF, Figueroa MS, Antela A, Quereda C, Perez-Elias MJ, et al. Retinal toxicity associated with didanosine in HIV-infected adults. AIDS 1996;10:1297–300.
Whitcup SM, Dastgheib K, Nussenblatt RB, Walton RC, Pizzo PA, Chan CC . A clinicopathologic report of the retinal lesions associated with didanosine. Arch Ophthalmol 1994;112:1594–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Curi, A., Freeman, G., Kapembwa, M. et al. Retinal toxicity due to Efavirenz. Eye 15, 246–248 (2001). https://doi.org/10.1038/eye.2001.81
Issue Date:
DOI: https://doi.org/10.1038/eye.2001.81
This article is cited by
-
Efavirenz and retinal toxicity
Eye (2002)